Clinical Trials Browser

Phase 1 × Cognitive Dysfunction × Donepezil × Clear all

NCT00594633 2016-01-14

Adjunctive Donepezil Therapy and Genetic Risk Factors of Cognitive Dysfunction in Brain Tumor Survivors

Phase 1 Completed

Brain Neoplasms, Central Nervous System Neoplasms, Cognitive Dysfunction